Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Stereotactic Body Radiation Therapy and 5-Fluorouracil, Oxaliplatin and Irinotecan (FOLFIRINOX) in the Neoadjuvant Therapy of Pancreatic Cancer

NCT01446458 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01446458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01446458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Stereotactic Body Radiation Therapy and 5-Fluorouracil, Oxaliplatin and Irinotecan (FOLFIRINOX) in the Neoadjuvant Therapy of Pancreatic Cancer
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2011
Completion date
March 31, 2015
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of pancreas, cancer of the pancreas, neoplasms, pancreatic, pancreas cancer, pancreas neoplasms